OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Cardiology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
The role of artificial intelligence in early detection and intervention of coronary artery disease	30
Genetics of sudden cardiac death	20
Assessment and management of neonates with unrepaired congenital heart disease	20
Editorial: from albuminuria to uric acid – emerging risk factors beyond lipids	20
Editorial introductions	19
REVIVED BCIS-2: update and key learnings	19
Vascular regenerative cells in cardiometabolic disease	16
Advances in device-based therapies for cardiorenal syndrome	16
Device therapy for heart failure management	15
Pemafibrate and other triglyceride-lowering therapies to reduce risk of cardiovascular and metabolic disease	15
Role of medical management of cardiogenic shock in the era of mechanical circulatory support	14
Donation after circulatory determination of death in heart transplant: impact on current and future allocation policy	13
Cardiac phenotypes in LMNA mutations	13
Editorial introductions	13
Clinical considerations and pathophysiological associations among obesity, weight loss, heart failure, and hypertension	12
Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care	12
Radiofrequency lesion formation prediction with contact force versus local impedance	12
Editorial introductions	12
Cardiac selectivity in pulsed field ablation	11
Editorial introductions	11
Imaging of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy	11
Wellness and burnout in cardiac surgery: not black and white	11
Multimodality cardiovascular imaging in hypertension	11
Sleep apnea and cardiovascular risk	11
Integration of palliative care across the spectrum of heart failure care and therapies: considerations, contemporary data, and challenges	10

Management of hypertension in heart transplant recipients: an ongoing conundrum	10
Bicuspid aortic valve associated aortopathy: 2022 guideline update	10
Near infrared spectroscopy in the pediatric cardiac intensive care unit: accurately interpreting the data	10
The mitral valve in hypertrophic cardiomyopathy	9
Mapping and ablation of intramural premature ventricular complexes: state-of-the-art review	9
Is the world ready for the STICH 3.0 trial?	9
Management of difficult coronary anatomy during transcatheter aortic valve implantation: what are the key issues?	9
Impact of glucagon-like peptide-1 receptor agonists on hypertension management: a narrative review	9
Weight loss and atrial fibrillation: a review	9
Bad behavior in healthcare: an insidious threat to patients, staff, and organizations	8
Albuminuria and cardiorenal risk	8
Expanding revascularization trials to women and underserved minorities and shifting to patient-centered outcomes: RECHARGE trials program	8
Tumours of the heart valves	8
Promoting gender diversity and ergonomic equity in the cardiac surgery operating room	8
Electrographic flow mapping of atrial fibrillation	8
When should the tricuspid valve be repaired during mitral valve repair?	7
Artificial sweeteners and cardiovascular risk	7
Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation: who should receive it in current clinical practice?	7
Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?	7
Clinical trials of cell therapy for heart failure: recent results warrant continued research	7
Disparity issues in coronary artery surgery	7
Robotic mitral valve surgery: evolving history, techniques, and training paths	7
New wrinkles in hypertension management 2022	7
Symptoms, coronary artery disease and percutaneous coronary intervention: connecting the dots	7
Improving diversity in cardiac surgery clinical trials with ROMA:Women as an exemplar	7
Editorial introductions	7
2025 ESC/EACTS valvular heart disease guidelines: key updates and surgical implications for cardiac surgeons	7
How to deal with nonsevere stenoses in coronary artery bypass grafting – a critical perspective on competitive flow and surgical precision	6
Electronic health strategies to improve medication adherence in patients with cardiometabolic disease: current status and future directions	6
Clinical impact of genetic testing for lipid disorders	6
Mitral valve surgery after failed transcatheter edge-to-edge repair: a review and word of caution	6
Destination LVAD therapy in the current era of the heart transplant allocation system	6
Influenza vaccination in mitigating vascular events and risk	6
Management of pregnancy in left ventricular assist device and heart transplant recipients: a concise review	6
Recent advances in cardiac imaging: emerging use of three-dimensional visualization for analyzing complex cardiovascular anatomy	6
Long noncoding RNAs in cardiovascular disease	6
Peripheral arterial disease and hypertension	6
Coronary artery calcium and sudden cardiac death: current evidence and future directions	6
Postmyocardial infarction ventricular septal rupture: optimizing surgical timing and repair	5
Double outlet right ventricle – the 50% rule has always been about the conus	5
Building resilient heart center teams	5
Teaching minimally invasive coronary artery bypass grafting: a structured framework for well tolerated adoption and training	5
Hypertrophic cardiomyopathy and competitive sports: let ‘em play?	5
Statin-Associated muscle symptoms and vitamin D supplementation	5
High lipoprotein(a) is a risk factor for peripheral artery disease, abdominal aortic aneurysms, and major adverse limb events	5
Editorial introductions	5
Broadening the applicability of coronary surgery from minimally invasive approaches to the modern treatment of ventricular septal rupture	5
Editorial introductions	5
From remnant cholesterol to lipoprotein(a) – emerging risk factors for cardiovascular diseases beyond low density lipoprotein: Erratum	5
Left main revascularization guidelines: navigating the data	5

The management of new-onset atrial fibrillation in critical illness: an update on current therapeutic options	5
Patient selection in robotic mitral valve surgery	5
Pharmacogenetics of cardiovascular drugs	5
Congenitally corrected transposition: not correct at all	5
Editorial: the year in lipids and emerging risk factors	5